ANEB-001
ANEB-001 is an orally active CB1 inhibitor, can be used to research acute cannabinoid intoxication[1].
Product Specifications
CAS Number
[791848-71-0]
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/aneb-001.html
Purity
99.73
Solubility
10 mM in DMSO
Smiles
CC(C)(C)NC(N(C1)CC1O[C@H](C2=CC=C(C=C2)Cl)C3=C(C=CC=C3)C(F)(F)F)=O
Molecular Formula
C22H24ClF3N2O2
Molecular Weight
440.89
References & Citations
[1]Joseph Fenton Lawler, et al. Formulations and methods for treating acute cannabinoid overdose. US11141404B1
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
CB1
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
R1070-26D-AP 200 µL
RANBP9, ID (Ran-binding Protein 9, RanBP9, RanBP7, Ran-binding Protein M, RanBPM, BPM90, BPM-L) (AP) discontinued
Sign In for Pricing
View Details 
KLHL15-2242R 50 µg
Recombinant Rhesus Macaque KLHL15 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details